<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_HAFS skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:HAFS</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P>﻿
</P><H1 class="logo">iGEM HAFS</H1><NAV class="menu"><UL><LI><A href="#">PROJECT ▾</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Description">Description</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Applied_Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Model">Model</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Improve">Parts</A></LI></UL><LI><A href="#">HUMAN PRACTICES ▾</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Public_Engagement">Engagement</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/InterLab">INTERLAB</A></LI><LI><A href="#">TEAM ▾</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Team">Team</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Attributions">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:HAFS/Collaborations">Collaborations</A></LI></NAV><DIV style="width:100%; margin: 0 auto; background-color: #6C5B7B"><DIV id="abstract">ABSTRACT</DIV><DIV style="max-width:1000px; font-size:1.5em; margin: 2% auto; line-height:1.5; text-align:justify; color: white; padding-top:2%; padding-bottom: 2%">

Type 1 and 2 Diabetes mellitus (T1DM, T2DM) are both caused by inappropriate insulin production. The former results from the lack of ß cell, while the later results from insulin resistance and impaired function of ß cell. In order to treat T1DM as well as severe cases of T2DM, patients should inject insulin analog multiple times a day. Because these analogues are readily degraded upon oral intake, the only method of injecting insulin analog is via invasive methods. We aimed to develop minicell-based insulin delivery system that can be orally administered. Minicells are achromosomal cells that do not reproduce. The deletion of Min system in E. coli ME8077 strain induces abnormal cell division that produces minicells. We have engineered the minicell to produce single chain insulin (Winsulin) associated with cell penetrating peptide that facilitates cellular intake. The expression of insulin was assessed through Western Blot. The cells lyse in response to bile salt, which leads to targeted secretion and subsequent intake of insulin in duodenum. 


</DIV></DIV><DIV id="buttons"><DIV class="botao-link"><A href="https://2018.igem.org/Team:HAFS/Description"><DIV class="overlay" id="projectdesc"><DIV class="text">project description</DIV></DIV></A></DIV><DIV class="botao-link"><A href="https://2018.igem.org/Team:HAFS/Applied_Design"><DIV class="overlay" id="design"><DIV class="text">design</DIV></DIV></A></DIV><DIV class="botao-link"><A href="https://2018.igem.org/Team:HAFS/Results"><DIV class="overlay" id="result"><DIV class="text">results</DIV></DIV></A></DIV><DIV class="botao-link"><A href="https://2018.igem.org/Team:HAFS/Human_Practices"><DIV class="overlay" id="hpp"><DIV class="text">human practices</DIV></DIV></A></DIV><DIV class="botao-link"><A href="https://2018.igem.org/Team:HAFS/Team"><DIV class="overlay" id="team"><DIV class="text">team</DIV></DIV></A></DIV></DIV><TITLE>Team: AQA_Unesp</TITLE><DIV id="footer"><DIV id="contact" class="btm_box"><P>
			Hankuk Academy of Foreign Studies 
			International studies
			Gyeong gi, South Korea
			kyuhee0622@gmail.com</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>